Cargando…
479. Real-world Evaluation of SARS-CoV-2 Monoclonal Antibodies in Solid Organ Transplant Recipients
BACKGROUND: Patients with COVID-19 infection at highest risk for poor outcomes include immunocompromised patients, such as solid organ transplant (SOT) recipients. Monoclonal antibody (mAb) infusions were developed to promote passive immunity. Analysis of the first 200 patients who received SARS-CoV...
Autores principales: | Zeitler, Kristen, Piccicacco, Nicholas, Bowman, Lyndsey, Montero, Jose, Cancio, Margarita, Houston, Sally, Kim, Kami |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644374/ http://dx.doi.org/10.1093/ofid/ofab466.678 |
Ejemplares similares
-
The impact of an antimicrobial stewardship program restriction on remdesivir prescribing
por: Zeitler, Kristen E., et al.
Publicado: (2022) -
Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Infusions in High-Risk Outpatients
por: Piccicacco, Nicholas, et al.
Publicado: (2021) -
The Greek world, 479-323 BC
por: Hornblower, Simon
Publicado: (1991) -
213. An Analysis of the Impact of Gastrointestinal Polymerase Chain Reaction Panel Use on Antimicrobial use at a Tertiary Care Academic Medical Center
por: Nlandu, Zola, et al.
Publicado: (2020) -
Monoclonal Antibody Therapy for COVID-19 in Solid Organ Transplant
Recipients
por: Yetmar, Zachary A, et al.
Publicado: (2021)